LAVA Therapeutics NV
Biotechnology
Healthcare
LVTX
26.31 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.57
52 week high
2.34
high
1.59
52 week low
0.00
previous Close
1.56
P/E ratio
market cap
39.98 M
div yield
0
net incoming
-8.64 M
-148.32 %
net profit margin
-863900000.00 %
0.00 %
operating incoming
-7.29 M
3.94 %
net change in cash
-16.25 M
-448.70 %
cash on hand
26.38 M
-33.51 %
top